For the Inventor, By the Inventor

Enter assignee name

Alberta, Canada

Synphar Laboratories, Inc.

Calculating rank

USPTO Granted Patents = 21

Forward Citations = 188

Loading Chart...

Loading Chart...

48 inventors (with patents filed for the assignee):

Ronald G Micetich (15 out of 42 patents)

Rajeshwar Singh (7 out of 38 patents)

Samarendra N Maiti (6 out of 22 patents)

4. Mohsen Daneshtalab (5 out of 6 patents)

5. Dai Q Nguyen (5 out of 14 patents)

6. Chan M Ha (5 out of 5 patents)

7. Ronald J Micetich (5 out of 6 patents)

8. Paul Spevak (4 out of 5 patents)

9. David P Czajkowski (4 out of 5 patents)

10. Charles Y Fiakpui (4 out of 6 patents)

11. Inder Pal Singh (3 out of 11 patents)

12. George Thomas (3 out of 5 patents)

13. Inderjit Sidhu (3 out of 3 patents)

14. Tomohiro Yamashita (3 out of 6 patents)

15. Hiroshi Matsumoto (3 out of 7 patents)

21 patents: Sort by Forward Citations

1. 6153616 - Triazoles as therapeutic agents for fungal infections (2000-11-28),

2. 6133485 - Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl (2000-10-17),

3. 5994342 - 3-(substituted methyl)-4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives (1999-11-30),

4. 5994340 - Azetidinone derivatives as .beta.-lactamase inhibitors (1999-11-30),

5. 5986108 - 4-substitued-3-[1 or 2 amino acid residue]-azetidin-2-one derivatives (1999-11-16),

6. 5959123 - 3,4-Disubstituted azetidin-2-one derivatives useful as cysteine (1999-09-28),

7. 5888998 - 2-oxo-1-azetidine sulfonic acid derivatives as potent .beta.-lactamase (1999-03-30),

8. 5652234 - 3-(7-oxo-1-aza-4-oxabicyclo[3.2.0]hept-3-yl)alanine derivative as (1997-07-29),

9. 5616606 - Oligopeptide antiretroviral agents (1997-04-01),

10. 5561126 - 4-oxa-1-azabicyclo [3,2,0] heptan-7-one derivatives as antitumor agents (1996-10-01),

11. 5530134 - Synthesis of anabaseine, salts and derivatives thereof (1996-06-25),

12. 5502068 - Cyclopropylpyrroloindole-oligopeptide anticancer agents (1996-03-26),

13. 5478947 - Effective process for the production of 1,2,3-triazoles (1995-12-26),

14. 5446037 - 2-[(substituted) methylene]cephalosporin sulfones as antiinflammatory, (1995-08-29),

15. 5439904 - 2-spiro(2'-spirocycloalkyl)cyclopropyl cephalosporin sulfones as (1995-08-08),

Company Overview

Synphar Laboratories, Inc. is a biotechnology company based in Alberta, Canada, specializing in the development and manufacturing of innovative pharmaceutical products. The organization focuses on advanced drug delivery systems and formulations, aiming to enhance therapeutic efficacy and patient compliance. With a commitment to research and development, Synphar is dedicated to addressing unmet medical needs through cutting-edge technologies and collaborative partnerships in the healthcare sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

21 Patents

#1 in Alberta

#685 in Canada

#30,001 in the World

Alberta, Canada

Synphar Laboratories, Inc.

Forward Citations = 188

48 inventors:

Ronald G Micetich (15 out of 42 patents)

Rajeshwar Singh (7 out of 38 patents)

Samarendra N Maiti (6 out of 22 patents)

4. Mohsen Daneshtalab (5 out of 6 patents)

5. Dai Q Nguyen (5 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Synphar Laboratories, Inc.. Retrieved from https://idiyas.com/company/synphar-laboratories

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…